Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Caroline S. Broome
Enhanced Recovery From Contraction-Induced Damage in Skeletal Muscles of Old Mice Following Treatment With the Heat Shock Protein Inducer 17-(Allylamino)-17-Demethoxygeldanamycin
Rejuvenation Research
Aging
Gerontology
Geriatrics
Related publications
Novel Mechanism of Attenuation of LPS-Induced NF-κB Activation by the Heat Shock Protein 90 Inhibitor, 17-N-Allylamino-17-Demethoxygeldanamycin, in Human Lung Microvascular Endothelial Cells
American Journal of Respiratory Cell and Molecular Biology
Respiratory Medicine
Pulmonary
Clinical Biochemistry
Cell Biology
Molecular Biology
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator
Clinical Cancer Research
Cancer Research
Oncology
Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients With Refractory Advanced Cancers
Clinical Cancer Research
Cancer Research
Oncology
Sulforaphane Potentiates the Efficacy of 17-Allylamino 17-Demethoxygeldanamycin Against Pancreatic Cancer Through Enhanced Abrogation of Hsp90 Chaperone Function
Nutrition and Cancer
Medicine
Nutrition
Oncology
Cancer Research
Dietetics
17-Allylamino-17-Demethoxygeldanamycin Down-Regulates Hyaluronic Acid-Induced Glioma Invasion by Blocking Matrix Metalloproteinase-9 Secretion
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Hsp70 Inducer, 17-Allylamino-Demethoxygeldanamycin, Provides Neuroprotection via Anti-Inflammatory Effects in a Rat Model of Traumatic Brain Injury
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Cooperative Enhancement of Radiosensitivity After Combined Treatment of 17-(Allylamino)-17-Demethoxygeldanamycin and Celecoxib in Human Lung and Colon Cancer Cell Lines
DNA and Cell Biology
Medicine
Genetics
Cell Biology
Molecular Biology